Spinal Muscular Atrophy: From Gene to Therapy
- 30 June 2006
- journal article
- review article
- Published by Elsevier in Seminars in Pediatric Neurology
- Vol. 13 (2) , 121-131
- https://doi.org/10.1016/j.spen.2006.06.008
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Determinants of Exon 7 Splicing in the Spinal Muscular Atrophy Genes, SMN1 and SMN2American Journal of Human Genetics, 2006
- Somatic mosaicism for a heterozygous deletion of the survival motor neuron (SMN1) geneEuropean Journal of Human Genetics, 2004
- An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophyBiochemical and Biophysical Research Communications, 2004
- Evidence for a modifying pathway in SMA discordant families: reduced SMN level decreases the amount of its interacting partners and Htra2-beta1Human Genetics, 2003
- Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfindingThe Journal of cell biology, 2003
- Development of a Gene Therapy Strategy for the Restoration of Survival Motor Neuron Protein Expression: Implications for Spinal Muscular Atrophy TherapyHuman Gene Therapy, 2003
- Differential Intranuclear Localization of Fibroblast Growth Factor-2 Isoforms and Specific Interaction with the Survival of Motoneuron ProteinJournal of Biological Chemistry, 2003
- Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosisAnnals of Neurology, 2002
- Osteoclast-stimulating Factor Interacts with the Spinal Muscular Atrophy Gene Product to Stimulate Osteoclast FormationJournal of Biological Chemistry, 2001
- SMN oligomerization defect correlates with spinal muscular atrophy severityNature Genetics, 1998